Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination

BACKGROUND: Immunotherapy is currently part of the standard of care for patients with advanced-stage non-small cell lung cancer (NSCLC). However, many patients do not respond to this treatment, therefore combination strategies are being explored to increase clinical benefit. The PEMBRO-RT trial comb...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Woude, Lieke L, Gorris, Mark A J, Wortel, Inge M N, Creemers, Jeroen H A, Verrijp, Kiek, Monkhorst, Kim, Grünberg, Katrien, van den Heuvel, Michel M, Textor, Johannes, Figdor, Carl G, Piet, Berber, Theelen, Willemijn S M E, de Vries, I Jolanda M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577911/
https://www.ncbi.nlm.nih.gov/pubmed/36252995
http://dx.doi.org/10.1136/jitc-2022-005248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577911/
https://www.ncbi.nlm.nih.gov/pubmed/36252995
http://dx.doi.org/10.1136/jitc-2022-005248

Ejemplares similares